Brain tumor, breast cancer, colon cancer, congenital heart disease, heart arrhythmia. See more conditions.
The research interests of Benjamin R. Kipp, Ph.D., include the development of molecular genetic assays for the diagnosis, prognosis and treatment of solid tumors; clinical next-generation sequencing (NGS) technology for hereditary and somatic diseases; and molecular cytology and circulating tumor assays for diagnosis, prognosis and treatment of multiple cancer types.
Dr. Kipp and colleagues have developed and implemented numerous clinical tests that aid clinicians in the diagnosis, prognosis and treatment of cancer. The goal of his research is to develop and implement newer technologies to detect cancer earlier, when it is still amenable to curative treatment, or to identify novel therapeutic targets in patients with advanced cancers who may benefit from newer therapies.
Learn about clinical trials that address specific scientific questions about human health and disease.
Explore all research studies at Mayo Clinic.
See the peer-reviewed findings I have published as a result of my research.
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products and services advertised.
A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy Living," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.